| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 02/15/2007 | US20070036770 Biologic device for regulation of gene expression and method therefor |
| 02/15/2007 | US20070036769 BMP pathway methods and compositions |
| 02/15/2007 | US20070036764 Selective killing of cells by activation of double-stranded RNA dependent protein kinase-PKR |
| 02/15/2007 | US20070036763 Interleukin-17 receptor homologue |
| 02/15/2007 | US20070036762 Nucleic acid and corresponding protein entitled 85P1B3 useful in treatment and detection of cancer |
| 02/15/2007 | US20070036761 Lentiviral apoe2 gene therapy |
| 02/15/2007 | US20070036760 Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor |
| 02/15/2007 | US20070036759 Method of preparing a proliferation-regulated recombinant adenoviral vector efficiently and kit for preparing the same |
| 02/15/2007 | US20070036758 Mutants of vaccinia virus as oncolytic agents |
| 02/15/2007 | US20070036757 Aav vector for gene therapy |
| 02/15/2007 | US20070036756 Method for treating ischemic diseases |
| 02/15/2007 | US20070036748 Combination therapies for cancer |
| 02/15/2007 | US20070036740 Modulation of hair growth |
| 02/15/2007 | CA2658678A1 Composition and method for prevention and treatment of type i diabetes |
| 02/15/2007 | CA2618580A1 Use of common .gamma. chain cytokines for the visualization, isolation and genetic modification of memory t lymphocytes |
| 02/15/2007 | CA2618542A1 Prophylactic/therapeutic agent for cancer |
| 02/15/2007 | CA2617807A1 Methods for treating and detecting beta-cell disease |
| 02/15/2007 | CA2616069A1 Suppression of b-cell apoptosis in transgenic animals expressing humanized immunoglobulin |
| 02/14/2007 | EP1752539A2 cDNA for human methylenetetrahydrofolate reductase |
| 02/14/2007 | EP1752536A1 Polynucleotide causing rna interfere and method of regulating gene expression with the use of the same |
| 02/14/2007 | EP1752160A2 Epitope sequences |
| 02/14/2007 | EP1751291A1 Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine |
| 02/14/2007 | EP1751289A1 Tc-83-derived alphavirus vectors, particles and methods |
| 02/14/2007 | EP1751285A2 Pharmaceutical compositions for use in the treatment of allergic diseases, pathological changes of the respiratory system and cancer via modulation of stat6 gene expression |
| 02/14/2007 | EP1751178A2 Nucleic acids, polypeptides, methods of expression, and immunogenic compositions associated with sars corona virus spike protein |
| 02/14/2007 | EP1750776A2 Oligonucleotides comprising a c5-modified pyrimidine |
| 02/14/2007 | EP1750775A2 Compositions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells |
| 02/14/2007 | EP1750774A2 Composition and method of cancer treatment |
| 02/14/2007 | EP1750773A1 Drugs for the prevention or treatment of immunodeficiencies, autoimmune diseases or for the induction of immune tolerance |
| 02/14/2007 | EP1750772A1 Phospholipase c gamma modulation and uses thereof for management of pain and nociception |
| 02/14/2007 | EP1750771A2 Pancreatic islet microrna and methods for inhibiting same |
| 02/14/2007 | EP1750748A1 Use of the foamy virus bet protein for inactivating apobec |
| 02/14/2007 | EP1750671A1 Liposomal assembly for therapeutic and/or diagnostic use |
| 02/14/2007 | EP1750666A2 Methods and articles for the delivery of therapeutic agents |
| 02/14/2007 | EP1417228B1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 02/14/2007 | EP1124959B1 Cell surface molecule-induced macrophage activation |
| 02/14/2007 | EP1066055B1 Horse DNA vaccines containing the adjuvant acrylic acid, methacrylic acid or EMA (R) |
| 02/14/2007 | EP0871713B1 The use of lecithin-cholesterol acyltransferase (lcat) in the treatment of atherosclerosis |
| 02/14/2007 | EP0662077B1 Cd27 ligand |
| 02/14/2007 | CN1914335A Antisense oligonucleotide modulation of STAT3 expression |
| 02/14/2007 | CN1914313A Medium for preparing feeder cells for embryonic stem cells and feeder cells |
| 02/14/2007 | CN1913923A Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells |
| 02/14/2007 | CN1912141A Identification of genes |
| 02/14/2007 | CN1911960A Chlamydia protein, gene sequence and uses thereof |
| 02/14/2007 | CN1300312C Structure and use of anti-hypatitis B virus antisense oligonucleotide of target de-sialoglycoprotein receptor |
| 02/14/2007 | CN1299769C Human papilloma virus and heat shock protein recombinant protein vaccine and use thereof |
| 02/13/2007 | US7176304 useful in modulating vascular endothelial growth factor (VEGF) and/or vascular endothelial growth factor receptor (e.g., VEGFR) gene expression; used in therapeutic, diagnostic, target validation, and genomic discovery |
| 02/13/2007 | US7176303 Modulation of STAT5 expression |
| 02/13/2007 | US7176302 Delivery system for antisense oligonucleotides involves a liposomal composition, comprising a liposome which consists essentially of neutral phospholipids and an antisense oligonucleotide that is entrapped in the liposome and is |
| 02/13/2007 | US7176299 Compounds |
| 02/13/2007 | US7176294 Transcription factor, BP1 |
| 02/13/2007 | US7176276 Antimicrobial peptide and use thereof |
| 02/13/2007 | US7176191 Bi phosphate containing protonated compound with two end groups; disinfecting surfaces of surgical equipments and skin |
| 02/13/2007 | US7176186 Stimulation of cell-mediated immune responses by targeted particulate genetic immunization |
| 02/13/2007 | US7176180 Fusion proteins; immunoglobulins; kits |
| 02/13/2007 | US7176179 Polypeptide characterized by: a) a nuclear localization sequence, b) amino acid residues 75 108 of SEQ ID NO:2 retaining selective apoptosis-inducing activity, and c) an affinity ligand |
| 02/13/2007 | US7176178 Protein H and its fragments/derivatives are capable of interacting with nucleophosmin/B23, actin, NPM/B23, protein SET or hnRNP A2/B1 |
| 02/13/2007 | US7176022 Directly injectable formulations which provide enhanced cryoprotection of cell products |
| 02/13/2007 | US7176019 For modulating NF- kappa B signaling |
| 02/13/2007 | US7176010 Encoded amino acid sequences, DNAs encoding the proteins, recombinant vectors, culturing, drugs comprising the proteins or DNAs, antibodies, drug screening, for arteriosclerosis, hyperlipidemia, obesity or mellitus diabetes |
| 02/13/2007 | US7175988 Human G-protein Chemokine Receptor (CCR5) HDGNR10 |
| 02/13/2007 | US7175842 Methods of modulating hair growth |
| 02/13/2007 | US7175840 Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof |
| 02/13/2007 | CA2124958C Inhibitory immunoglobulin polypeptides to human pdgf beta receptor |
| 02/12/2007 | CA2553115A1 Modulation of peroxisome proliferation-activated receptors |
| 02/08/2007 | WO2007016620A2 Methods and compositions for regenerating articular cartilage |
| 02/08/2007 | WO2007016189A2 Glucose transport-related genes, polypeptides, and methods of use thereof |
| 02/08/2007 | WO2007015704A2 Modified bacteriophage vectors and uses thereof |
| 02/08/2007 | WO2007015587A1 Apoptosis promoter, cell proliferation inhibitor, prophylactic/therapeutic agent for cancer, screening method for the promoter, inhibitor or agent |
| 02/08/2007 | WO2007015540A1 Cytotoxic t-cell epitope peptide and use thereof |
| 02/08/2007 | WO2007015122A1 Therapy for alzheimer’s disease |
| 02/08/2007 | WO2007014469A1 Hepatitis c antivirals |
| 02/08/2007 | WO2007014415A1 Helminth antigen and immunotherapy |
| 02/08/2007 | WO2006127452A3 Methods and compositions for modulating the activity of peptidases in macrophage and macrophage-like cells |
| 02/08/2007 | WO2006067506A3 Hiv resistance genes |
| 02/08/2007 | WO2005110490A8 Phospholipase c gamma modulation and uses thereof for management of pain and nociception |
| 02/08/2007 | WO2005044987A3 Tocopherol associated protein and uses thereof |
| 02/08/2007 | US20070032642 Novel genes and their use in the modulation of obesity, diabetes and energy imbalance |
| 02/08/2007 | US20070032447 Production of reprogrammed cells with restored potential |
| 02/08/2007 | US20070032446 Gapped 2' modified oligonucleotides |
| 02/08/2007 | US20070032445 Antisense IAP nucleobase oligomers and uses thereof |
| 02/08/2007 | US20070032444 Genetic immunization with nonstructural proteins of hepatitis C virus |
| 02/08/2007 | US20070032443 Therapy for Alzheimer's disease |
| 02/08/2007 | US20070032442 Vector utilizing ribonuclease reductase UTR and use for inhibiting neoplastic cells |
| 02/08/2007 | US20070032441 treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability |
| 02/08/2007 | US20070032440 Oligonucleotides directed against a survivin gene and use thereof |
| 02/08/2007 | US20070032439 Tarp promoter and uses thereof |
| 02/08/2007 | US20070032416 Chorionic somatomammotropin hormone splice variants |
| 02/08/2007 | US20070032415 Compositions, splice variants and methods relating to breast specific genes and proteins |
| 02/08/2007 | US20070032413 Of given amino acid sequence; vectors, host cells, and recombination; diagnosing and treating diseases related to human secreted proteins |
| 02/08/2007 | US20070031936 Nucleic acid sequences having gene transcription regulatory qualities |
| 02/08/2007 | US20070031935 Nucleic acid sequences having gene transcription regulatory qualities |
| 02/08/2007 | US20070031934 Nucleic acid sequences having gene transcription regulatory qualities |
| 02/08/2007 | US20070031933 Determining whether a DNA sequence comprises a gene transcription modulating quality and/or a gene transcription repressing quality; systematic elucidation and identification of regulatory sequences |
| 02/08/2007 | US20070031904 Mammalian IAP gene family, primers, probes and detection methods |
| 02/08/2007 | US20070031903 Mammalian IAP gene family, primers, probes and detection methods |
| 02/08/2007 | US20070031897 Methods and compositions for treating and diagnosing diabetes and related diseases involving beta-TRP |
| 02/08/2007 | US20070031888 Human leucine-rich repeat containing protein expressed predominately in small intestine, HLRRSI1 |
| 02/08/2007 | US20070031882 Methods and compositions for treating AIDS and HIV-related disorders using 1414, 1481,1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784 or 2045 molecules |
| 02/08/2007 | US20070031878 Methods and compositions for polypeptide engineering |